Mortara Instrument and Spacelabs Healthcare Announce VERITAS™ Licensing Agreement

Milwaukee, WI (June 23, 2008)––Mortara Instrument announced today that it has reached agreement with  Spacelabs Healthcare  to extend the term of the licensing agreement for Mortara’s VERITAS Resting ECG Interpretation Algorithm.  The extension will provide for Spacelabs to continue using the Mortara VERITAS algorithm in both current and future patient monitoring product offerings. 

“We are pleased to renew our relationship with Spacelabs Healthcare,” commented Justin Mortara, Ph.D., Vice President of Mortara. “Providing our VERITAS algorithm for use in Spacelabs’ patient monitoring platform expands the reach of our best in class ECG technology beyond diagnostic cardiology as we have always done.  In almost any arena where the ECG signal is used, one can find Mortara technology processing the data.  From fitness centers to patient monitoring, from the clinical trials to remote and home monitoring, Mortara VERITAS algorithms are used across a diverse spectrum of applications.”

Spacelabs Healthcare’s Joe Davin, Group President North American Operations stated, “Our strengthened partnership with Mortara Instrument reinforces our commitment to providing healthcare organizations worldwide with the most advanced technologies to assess and treat their patients. Once again, we are connecting innovation with care.”

Mortara Instrument is a leading provider of non-invasive diagnostic ECG products under the Mortara brand, all of which utilize the VERITAS algorithms.  In addition, the company licenses its ECG components and VERITAS algorithms under the Heart of Mortara brand to medical device companies worldwide. 

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) is an international developer, manufacturer and distributor of medical equipment and services including patient monitoring solutions, anesthesia delivery and ventilation systems, diagnostic cardiology solutions and supplies and accessories selling to hospitals, clinics and physicians offices. Additionally, the company provides ECG laboratory services to pharmaceutical companies undertaking clinical trials, whereby patient ECG data is recorded, analyzed, tabulated and interpreted. It employs approximately 1,100 personnel in its offices located in the United States, UK, Canada, France, Germany, Finland, India and Singapore.

About Mortara Instrument

Mortara Instrument, Inc., based in Milwaukee, is distinguished in the field of non-invasive cardiology for innovations that are the core of the company’s complete line of ECG products including electrocardiographs, stress exercise systems, Holter systems and data warehousing solutions, and cardiology monitoring systems. The company’s website is www.mortara.com.